Histopathological risk stratification for early-stage endometrial cancer patients receiving adjuvant vaginal brachytherapy
Our histopathological risk stratification model could successfully differentiate the high-risk group from others in early-stage endometrial cancer patients. This model provides crucial prognostic information and could be helpful, especially in resource-limited settings where molecular classification might not be readily available.
Authors
- Yoo-Young Lee (ORCID: https://orcid.org/0000-0001-5902-9877)
- Chel Hun Choi (ORCID: https://orcid.org/0000-0002-0199-6669)
- Won Seo Park (ORCID: https://orcid.org/0000-0002-0774-7911)
- Won Kyung Cho (ORCID: https://orcid.org/0000-0002-7161-7249)
- Jeong‐Won Lee (ORCID: https://orcid.org/0000-0002-6110-4909)
- Tae‐Joong Kim (ORCID: https://orcid.org/0000-0002-9693-9164)
- Hae Sol Lim
Institutions
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Radiation Oncology Journal
- Published
- 2025-12-04
- DOI
- https://doi.org/10.3857/roj.2025.00612
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00